The Diversion Software Comparison No Vendor Wants You to See

This isn’t just a software comparison — it’s a strategic survival guide. Learn what every compliance team needs to know before committing to a vendor.
Unlock the 2026 Vendor Comparison

Get Your Free Report

Download the complete 2026 market comparison

Built for Decision-Makers Who Can’t Afford a Wrong Call

If you oversee diversion monitoring or vendor selection — this report is for you.

It’s built for:

Directors of Pharmacy

Compliance Officers

Diversion Investigators

Hospital Execs + Risk Teams

Contact Us

In 2026, this is no longer just a software decision. It's a strategic risk decision — with regulatory, reputational, and financial impact.

This report helps you:

  • Cut through vendor marketing.
  • Understand the real post-acquisition shifts.
  • Make the right call before your next renewal or RFP.

What You'll Discover Inside the 2026 Comparison Report

9 Vendor Breakdowns

including Sentri7, Bluesight, Quva, Imprivata, and more

Suite vs. Specialist Showdown

how consolidation is reshaping your choices

Service Model Smackdown

SaaS vs. high-touch vs. DMaaS (and who's left behind)

Why Most "Investigations" Still Miss Diversion

and what software alone can't solve

The Silent Risk in Renewing Your Current Vendor

especially after acquisition

This isn’t marketing fluff. It’s the strategic lens your team needs to make informed, future-proof decisions.

8 Vendors. One Report. Unfiltered.

Vendors covered in the report:

Wolters Kluwer

(Sentri7)

Bluesight

(ControlCheck)

Quva Pharma

(BrightStream)

Imprivata

(Drug Diversion Intelligence)

iatricSystems

(DetectRx)

Omnicell

(MAAP Analytics)

HelioMetrics

(The Customization & Data Validation Specialist)

BD

(HealthSight Diversion Management)

Download Report

What No One's Telling You About Diversion Software

Most “software comparisons” look at features. We looked at what actually happens after the contract is signed.

After sitting inside hundreds of real diversion investigations, one truth stands out:

It’s not the software that fails. It’s the model behind it.

We wrote this report to show what’s really changed — and what it means for outcomes, accountability, and risk.

The 2026 market has shifted:

  • Independent tools have been swallowed by big healthtech suites
  • SaaS platforms offer speed — but often cut out expertise
  • "High-touch" options vanish after onboarding
  • And most buyers don't know what they're really signing up for

If you’re still comparing features, you’re already behind.

Trusted by Compliance and Pharmacy Leaders Nationwide

Terri is absolutely phenomenal. She is an incredibly knowledgeable pharmacy resource. As the medication safety officer, the quality initiatives she implemented not only impacted the patients at our medical center but also reached into the community. Terri is a genuine professional who upholds accountability while creating community among her team members. She is a great listener to identify friction points and has actionable ideas to implement improvements.

CLS Lab T. Eagle. MBA, MLS(ASCP), CLS Lab Operations Manager

Terri is an expert at prospective risk identification -Failure, Mode and Effects Analysis (FMEA). Terri participated in CHPSO Patient Safety Safe Tables and was part of the Hospital Quality Institute’s Regional Quality and Patient Safety Leader Network.

Regional Quality Network at HQI A. Munoz, FACHE, CPHQ, CPPS VP

Terri has done more for the Pharmacy in her few months as Interim Pharmacy Director than any other Director has done during my 12 years here.

Anita Kennedy, MBA VP of Ancillary Services Methodist Hospital

Terri has always impressed me as being very smart. resourceful, creative, and easy to work with. Terri's commitment to medication safety permeated our organization, raising the awareness of this important issue throughout all levels of the institution. Terri has always been engaged, cooperative, and generous with her time.

Cary Mells, MD Chairman of the Department of Emergency Medicine
Tri-City Medical Center

Terri is knowledgeable and effective in pharmacy leadership. She has the ability to be able to anticipate and prepare for the future. Her ability to utilize resources effectively in this changing environment is a strong asset. She can adapt, evolve, mentor and still never say “no” when asked to assist. She exhibits great abilities to be flexible and is a “self starter”. She has a pleasant yet effective demeanor that commands results.

Candace Fong, Pharm D System Director of Pharmacy and Medication Safety
Common Spirit Health

In addition to understanding the ins and outs of the [controlled substance use] process completely, she is very proactive in coming to me with provider issues that she detects. She truly balances the administrative duties and the regulatory components demand with a keen sense of what my practitioners do and what their needs are on the ground. Terri is instrumental in working with my department, balancing patient care, cooperation, ability, and integrity to get the job done.

Chief Anesthesiologist UCSD Medical Center

We would not be where we are with the improvements we have made with opioid prescribing if it were not for Terri driving the process.

Chief Physician, Tri-City Emergency Medical Group Chief Physician

Terri has done a tremendous job with the controlled substance diversion program. She has had such a positive impact and has really made the hospital a safer place.

Nurse Manager, Tri-City Medical Center Nurse Manager

Get the 2026 Drug Diversion Software Market Report

Includes breakdowns of 9 major vendors, post-acquisition market shifts, and expert insights into the risks behind each service model.

Download the Report Now
diversion monitoring vendor

Why Hospitals Call Us When Diversion Software Fails

Rxpert Solutions isn’t a software company.

We’re a team of diversion surveillance experts who get called in after the system failed to catch it.

Our founder, Terri Vidals, is a nationally recognized diversion specialist with decades of experience in:

  • Pharmacy operations
  • Diversion investigations
  • Audit remediation
  • Compliance leadership

She’s been inside real hospital cases — where someone got hurt, data got missed, and the software didn’t catch it. She’s worked alongside DEA, internal audit, and compliance officers to fix it.

That’s the lens behind this report.

“I’ve been in the room when a software alert was ignored, and a patient was harmed. That’s why this report isn’t soft — it’s what I wish decision-makers had before things went wrong.”

— Terri Vidals

Founder, Rxpert Solutions

Frequently Asked Questions

Is this report just a pitch for your services?

No. We don’t sell software. We wrote this because we’ve seen too many hospitals choose tools that look good on paper — but fail when it matters. This report helps you make smarter decisions, no matter which vendor you choose.

Yes. Most of our clients come to us after they’ve already signed — usually when issues surface. This report helps you evaluate if your current setup still fits your needs in 2026’s post-consolidation market.

It’s not fluff or a one-pager. You’ll get:

  • A breakdown of 9 major vendors
  • Market analysis on service models and risks
  • Tactical insights for compliance and pharmacy leads

PDF format. Easy to skim, valuable to share.

Yes, it’s free. You’ll get instant access with no strings.
 We may follow up once to see if you have questions — but you will not get added to a sales pipeline.

Absolutely. It’s designed to inform internal discussions and vendor evaluations. Forward it, print it, bring it to your next renewal meeting.